The Flowr (TSXV:FLWR.H) EBIT per Share : C$-0.24 (TTM As of Sep. 2022)

View and export this data going back to 2017. Start your Free Trial

What is The Flowr EBIT per Share?

The Flowr's EBIT per Share for the three months ended in Sep. 2022 was C$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 was C$-0.24.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for The Flowr's EBIT per Share or its related term are showing as below:

TSXV:FLWR.H's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

The Flowr's EBIT for the three months ended in Sep. 2022 was C$-2.59 Mil.

The Flowr EBIT per Share Historical Data

The historical data trend for The Flowr's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Flowr EBIT per Share Chart

The Flowr Annual Data

Trend

Jun17

Jun18

Dec19

Dec20

Dec21

EBIT per Share

-0.01

-0.98

-0.37

-0.98

-0.24

The Flowr Quarterly Data
	Sep17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBIT per Share	Get a 7-Day Free Trial															-0.02	-0.18	-0.01	-0.04	-0.01

The Flowr EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

The Flowr's EBIT per Share for the fiscal year that ended in Dec. 2021 is calculated as

	EBIT per Share		(A: Dec. 2021 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-89.02	/	372.916
=	-0.24

The Flowr's EBIT per Share for the quarter that ended in Sep. 2022 is calculated as

	EBIT per Share		(Q: Sep. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.585	/	426.469
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.24

The Flowr (TSXV:FLWR.H) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

The Flowr EBIT per Share Related Terms

Thank you for viewing the detailed overview of The Flowr's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

The Flowr (TSXV:FLWR.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Flowr Corp (TSXV:FLWR.H) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

9590 McCarthy Road, Kelowna, BC, CAN, V4V 1R2

Website

https://www.flowr.ca

The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.

The Flowr (TSXV:FLWR.H) Headlines

No Headlines